Table 3 Laboratory tests results in COVID and non-COVID patients
From: The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Laboratory tests results | Non-COVID group n = 2412 | COVID group n = 180 | p value |
|---|---|---|---|
WBC (count/mm3) | 7 501 (18 690) | 8156 (8266) | 0.04 |
Platelets (mm3) | 119 882 (141 627) | 118 550 (130 685) | 0.38 |
C reactive protein (mg/L) | 80.15 (102.5) | 89.44 (98.35) | 0.002 |
AST U/L value | 90.9 (174) | 87.7 (108.4) | < 0.0001 |
ALT U/L value | 95.5 (150.3) | 94.6 (128.1) | 0.001 |
Total bilirubin (mg/dL) | 5.38 (26.24) | 9.07 (19.99) | < 0.0001 |
Conjugated bilirubin (mg/dL) | 2.31 (8.14) | 5.83 (15.89) | < 0.0001 |
Indirect bilirubin (mg/dL) | 2.43 (15.78) | 3.66 (6.39) | 0.001 |
GGT U/L value | 141.92 (201.64) | 131.5 (156.3) | 0.21 |
Procalcitonin (µg/L) | 4.05 (16.52) | 4.32(12.8) | 0.29 |
Lactate (mmol/L) | 16.96 (79) | 3.52 (12.73) | 0.03 |
Fibrinogen (g/L) | 307.34 (569.49) | 254.1 (322.2) | 0.29 |
D-dimer (nmol/L) | 456.8 (1644) | 858.5 (2382) | 0.02 |
Prothrombin time (s) | 18.1 (20.54) | 17.46 (16.29) | 0.5 |
APTT (s) | 26.39 (11.54) | 31.52 (8.94) | < 0.0001 |
INR | 1.4 (4.13) | 1.24 (0.71) | 0.017 |